Predicting Response to Naltrexone With Eye Tracking in Gaming Disorder
ConditionGaming Disorder
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-60
SponsorUniversity of Sao Paulo
About this trial
It is a double blind controlled study to test the hypothesis that it's possible to predict the response to naltrexone in Videogame Disorder with the use of Eye Tracking device, during a period of 12 weeks
Eligibility criteria
Qualifiers
Patients diagnosed with Internet Gaming Disorder according to DSM-5
Patients with craving according to the adaptation of the Gambling Follow-up Scale (GFS) described below.
I felt an irresistible urge to play.
I felt a strong desire to play, sometimes resistable, sometimes not.
Disqualifiers
- Established contraindication to naltrexone (opioid dependence, in the process of opioid withdrawal or current use of opioid analgesics) or hypersensitivity to naltrexone;
Exposure to any other drug or experimental device in the 30 days prior to inclusion, except for occasional use of benzodiazepines;
Pregnancy, breastfeeding or patients who intend to become pregnant during the study;
Evidence of renal failure, defined as serum creatinine levels> 133 mmol / L in men and> 124 mmol / L in women, which correspond to> 1.51 mg / dl and> 1.41 mg / dl, respectively on Week 1 of inclusion;
Trial design
Treatments tested in this trial
- Naltrexone group A
- Naltrexone
- Psychoeducational
- Eye-tracking
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov